Tacalcitol (1,24(OH)2D3 TV-O2) inhibits phorbol ester-induced epidermal proliferation and cutaneous inflammation, and induces epidermal differentiation in mice

Archives of Dermatological Research

Volumn 288, Issue 11, 1996, Pages 656-663

  Sato, Hiroaki ^a   Sugimoto, Izuki ^a   Matsunaga, Takashi ^a   Tsuchimoto, Masahiro ^a   Ohta, Tomohiro ^a   Uno, Hiroshi ^a   Kiyoki, Mamoru ^a  

^a TEIJIN LTD   (Japan)

Author keywords

1,24(OH)2D3; 1,25(OH)2D3; Betamethasone valerate; Psoriasis

Indexed keywords

ANTIPSORIASIS AGENT; BETAMETHASONE VALERATE; ORNITHINE DECARBOXYLASE; PHORBOL ESTER; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TACALCITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFICACY; ENZYME ACTIVITY; EPIDERMIS CELL; FEMALE; HISTOPATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; SKIN INFLAMMATION; TOPICAL DRUG ADMINISTRATION;

EID: 0029977942     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02505274     Document Type: Article

References (50)

1. Astrup EG, Iversen OH (1981) Cell population kinetics in hairless mouse epidermis following a single topical application of 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis 2(10): 999-1006
2. Burton K (1956) A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62:315-323
3. Burton K (1968) Determination of DNA concentration with diphenylamine. Methods Enzymol 12:163-166
4. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y (1982) Direct activation of calcium activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257:7847-7851
5. 3 of induction of epidermal ornithine decarboxylase caused by 12-O-tetradecanoylphorbol-13-acetate and teleocidin B. Cancer Res 44:1387-1391
6. 3 receptor in target cells. Endocrinology 122:1224-1230
7. Connerty HV, Briggs AR (1966) Determination of serum calcium by means orthocresolphthalein complexone. Am J Clin Pathol 45(3):290-296
8. Connor MJ, Lowe NJ (1983) Induction of ornithine decarboxylase activity and DNA synthesis in hairless mouse epidermis by retinoids. Cancer Res 43:5174-5177
9. Cooper KD, Baadsgaard O, Elder JT, Sauder DN, Voorhees JJ, Fisher GJ (1988) Increased levels of an interleukin-1 inhibitor block interleukin-1 activity but not immunoreactivity or mRNA expression of interleukin-1 beta in psoriasis skin. J Invest Dermatol 90:552
10. Esmann J, Cooper KD, Voorhees JJ, Fisher GJ (1988) Membrane associated transglutaminase activity is increased in psoriatic involved versus normal epidermis. J Invest Dermatol 90: 556
11. George MD, Vollberg TM, Floyd EE, Stein JP, Jetten AM (1990) Regulation of transglutaminase type II by transforming growth factor-β1 in normal and transformed human epidermal keratinocyte. J Biol Chem 265(19):11098-11104
12. 3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study. Br J Dermatol 131:57-63
13. Gupta AK, Fisher GJ, Elder JT, Nickoloff BJ, Voorhees JJ (1988) Sphingosine inhibits phorbol ester-induced inflammation, ornithine decarboxylase activity and activation of protein kinase C in mouse skin. J Invest Dermatol 91:486-491
14. Gupta AK, Fisher GJ, Elder JT, Talwar HS, Esmann J, Duell EA, Nickoloff BJ, Voorhees JJ (1989) Topical cyclosporine A inhibits the phorbol ester induced hyperplastic inflammatory response but not protein kinase C activation in mouse epidermis. J Invest Dermatol 93:379-386
15. 2a in the epidermis of psoriasis. Proc Natl Acad Sci USA 72:5130-5134
16. 3. Arch Dermatol 123:1677a-1683a
17. Horn F, Marks F, Fisher GJ, Marcelo CLK, Voorhees JJ (1987) Decreased protein kinase C activity in psoriatic versus normal epidermis. J Invest Dermatol 88:220-222
18. 3. Endocrinology 113:1950-1957
19. Inoue H, Tanioka H, Shiba K, Asada A, Kato Y, Takeda Y (1974) Effect of isoproterenol on polyamine metabolism in mouse salivary glands. J Biochem 75:679-687
20. 3 in rat pancreas. Mol Cell Endocrinol 60:109-117
21. Janne J, Raina A, Siimes M (1968) Stimulation of polyamine synthesis by growth hormone in rat liver. Biochim Biophys Acta 166:419-426
22. 3, 1α,24-hydroxycholecalciferol ointment. Acta Dermatol 84:43-436
23. Kay JE, Lindsay VJ (1973) Polyamine synthesis during lymphocyte activation. Exp Cell Res 77:428-436
24. 3 to induce keratinocyte differentiation. J Dermatol 17: 707-709
25. Kragballe K (1992) Vitamin D analogues in the treatment of psoriasis. J Cell Biochem 49:46-52
26. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K (1989) The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243(4897):1464-1466
27. 3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production. Biochem Biophys Res Commun 176(3):1020-1026
28. Marks F, Bertsch S, Furstenberger G (1979) Ornithine decarboxylase activity, cell proliferation, and tumor promotion in mouse epidermis in vivo. Cancer Res 39:4183-4188
29. Marks F, Fürstenberger G, Kownatzki E (1981) Prostaglandin E-mediated mitogenic stimulation of mouse epidermis in vivo by divalent cation ionophore A23187 and by tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 41:696-702
30. 3 on the growth of human keratinocytes. J Dermatol 17:97-103
31. 3 with high activity for inducing epidermal differentiation but decreased hypercalcemic activity. J Dermatol 17:135-142
32. Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lew W (1988) Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 167(6):1883-1893
33. 3. Med J Osaka Univ 35:51
34. Murdoch D, Clissold SP (1992) Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris. Drugs 43(3):415-429
35. Nair S, Mayotte J, Lokshin A, Levitt M (1994) Induction of squamous differentiation by interferon β in a human non-smallcell lung cancer cell line. J Natl Cancer Inst 86(5):378-383
36. 3 for the treatment of psoriasis. Review of the literature. Eur J Dermatol 3:255-261
37. O'Brien TG (1976) The induction of ornithine decarboxylase as an early, possibly obligatory, event in mouse skin carcinogenesis. Cancer Res 36:2644-2653
38. O'Brien TG, Simsiman RC, Boutwell RK (1975) Induction of polyamine-biosynthetic enzymes in mouse epidermis by tumor-promoting agents. Cancer Res 35:1662-1670
39. 3 (TV-02) (1): Plasma level, distribution metabolism and excretion after a single subcutaneous administraton to rats. Yakubutsu Doutai 5:3-24
40. 3 (TV-02) (3): Absorption, distribution and excretion after a single or continuous transcutaneous application to rats. Yakubutsu Doutai 5:39-52
41. Raick AN (1973) Ultrastructural, histological and biochemical alterations produced by 12-O-tetradecanoylphorbol-13-acetate on mouse epidermis and their relevance to skin tumor promotion. Cancer Res 33:269-286
42. Russell DH, Levy CC (1973) The roles of the polyamines, putrescine, spermidine, and spermine in normal and malignant tissues. Life Sci 13:1635-1647
43. Russell DH, McVicker TA (1971) Polyamine metabolism in mouse liver after partial hepatectomy. Biochim Biophys Acta 244:85-93
44. Russell DH, Snyder SH (1968) Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors. Proc Natl Acad Sci USA 68:1420-1426
45. Russell DH, Combest WL, Duell EA, Stawiski M, Anderson TF, Voorhees JJ (1978) Glucocorticoid inhibits elevated polyamine biosynthesis in psoriasis. J Invest Dermatol 71:177-181
46. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 86:709-714
47. Tanaka H, Abe E, Miyaura C, Kuribayashi T, Konno K, Nishii Y, Suda T (1982) 1α,25-Dihydroxycholecalciferol and a human myeloid leukemia cell line (HL-60): The presence of a cytosol receptor and induction of differentiation. Biochem J 204:713-719
48. Voorhees JJ (1983) Leukotrienes and other lipoxygenase products in pathogenesis and therapy of psoriasis and other dermatoses. Arch Dermatol 119:541-547
49. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, Leonard EJ (1987) Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 84(24):9233-9237
50. Yuspa SH, Ben T, Hennings H, Lichti U (1980) Phorbol ester tumor promoters induce epidermal transglutaminase activity. Biochem Biophys Res Commun 97:700-708